Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis

Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis

Alpha-mannosidosis is an inherited rare disorder of mannose-containing oligosaccharides metabolism that is currently treated by enzyme replacement therapy (ERT), bone marrow transplantation (BMT), or supportive therapy (ST). However, the relative cost-effectiveness of these treatment options is yet...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Antanasković, Ivana Stević, Refet Gojak, Dragana Lakić, Slobodan Janković
Format: Article
Language:English
Published: Taylor & Francis Group 2023-03-01
Series:Biotechnology & Biotechnological Equipment
Subjects:
Velmanase alfa
alpha-mannosidosis
cost-effectiveness
bone marrow transplantation
discrete event simulation
Online Access:https://www.tandfonline.com/doi/10.1080/13102818.2023.2271574
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/13102818.2023.2271574

Similar Items